- A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31604-4/fulltext 4 comments worldnews
- A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus. https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31604-4/fulltext 2842 comments science
Linking pages
- Oxford, CanSino and Pfizer COVID-19 vaccines trigger immune responses | Science News https://www.sciencenews.org/article/coronavirus-covid-19-vaccine-oxford-cansino-pfizer-immune-response 142 comments
- Fauci: 'We could start talking about real normality again' in 2021 | CNN Politics https://www.cnn.com/2020/07/23/politics/fauci-covid-2021-real-normality-axe-files/index.html?source_referral=fb_instant%3Fmedium%3Dandroid%3Fuser_app%3Dandroidmobile 70 comments
- Trump Reportedly Considers Fast-Tracking Unproven British Vaccine Before Election | HuffPost Latest News https://www.huffpost.com/entry/astrazeneca-oxford-trump-fast-track-vaccine-election_n_5f432285c5b697824f9a60c7 43 comments
- The truth about vaccines - UnHerd https://unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/ 9 comments
- Coronavirus LIVE: Delhi’s tally crosses 2-lakh mark; Serum Institute gets show-cause notice https://scroll.in/latest/972596/coronavirus-uk-firm-astrazeneca-pauses-vaccine-trial-after-volunteer-falls-ill 9 comments
- The Lancet: Oxford COVID-19 vaccine is safe a | EurekAlert! https://www.eurekalert.org/pub_releases/2020-12/tl-pss120820.php 8 comments
- The world needs a 'people's vaccine' for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima | The Guardian https://www.theguardian.com/commentisfree/2020/jul/23/world-needs-coronavirus-vaccine-big-pharma-monopoly-astrazeneca-patent-pandemic 6 comments
- Portland protests, COVID-19 vaccine, relief package, Nicki Minaj: Monday's news https://www.usatoday.com/story/news/2020/07/20/portland-protests-covid-19-vaccine-relief-package-nicki-minaj-mondays-news/5470224002/ 4 comments
- Track COVID-19 Vaccines Advancing Through Clinical Trials | The Scientist Magazine® https://www.the-scientist.com/news-opinion/covid-19-vaccine-frontrunners-67382 3 comments
- Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad | WIRED https://www.wired.com/story/covid-19-vaccines-with-minor-side-effects-could-still-be-pretty-bad/ 3 comments
- Coronavirus vaccine: why it's important to know what’s in the placebo https://theconversation.com/coronavirus-vaccine-why-its-important-to-know-whats-in-the-placebo-146365 1 comment
- Meet the 4 frontrunners in the COVID-19 vaccine race | Ars Technica https://arstechnica.com/science/2020/07/meet-the-4-frontrunners-in-the-covid-19-vaccine-race/ 0 comments
- Let's unclog the FDA and save lives! - by Dan Elton https://danelton.substack.com/p/lets-unclog-the-fda-and-save-lives 0 comments
- The very common vaccine ingredient at the center of J&J, AstraZeneca drama | Ars Technica https://arstechnica.com/science/2021/04/the-very-common-vaccine-ingredient-at-the-center-of-jj-astrazeneca-drama/ 0 comments
- The very common vaccine ingredient at the center of J&J, AstraZeneca drama | Ars Technica https://arstechnica.com/?p=1756985 0 comments
- Meet the 4 frontrunners in the COVID-19 vaccine race | Ars Technica https://arstechnica.com/?p=1693804 0 comments
- A COVID-19 Vaccine Reality Check - The Atlantic https://www.theatlantic.com/health/archive/2020/07/covid-19-vaccine-reality-check/614566/ 0 comments
Linked pages
- Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing | Clinical Infectious Diseases | Oxford Academic https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab638/6324310?redirectedFrom=fulltext 5618 comments
- ClinicalTrials.gov https://clinicaltrials.gov 35 comments
- COVID-19 vaccine tracker and landscape https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines 0 comments